Complexities in Interpretation of Osteosarcoma Clinical Trial Results
- 20 June 2008
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (18) , 3103-3104
- https://doi.org/10.1200/jco.2008.17.3484
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2008
- Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose MethotrexateJournal of Clinical Oncology, 2005
- Statistics notes: Absence of evidence is not evidence of absenceBMJ, 1995
- Factorial designs in clinical trials: The effects of non‐compliance and subadditivityStatistics in Medicine, 1989